14-day Premium Trial Subscription Try For FreeGet Free

Latest Data & Signals Issued

Signal Type Signal Value Data
Score -1.606 1 day ( 0 % )
Last Price $212.72 -0.230 %
High/ Low $212.44 - $213.97 0.471%
Chg 7 Days -0.81 % $214.45 $212.72
Chg 30 Days -0.770 % $214.37 $212.72
Chg 12 mos 75.77 % $121.02 $212.72
Trend - 3 mos 3.12 % Width: 4.55 %
Trend - 12 mos 58.02 % Width: 14.41 %
Pred. range - 3 mos $217.33 - $227.21 2.17 % - 6.81 %
Pred. range - 12 mos $319.43 - $365.46 50.17 % - 71.80 %
Short mv avg 3 mos Sell 2023-11-28 - 4 days
Long mv avg 3 mos Sell 2023-11-27 - 5 days
Short/Long mv avg 3 mos Sell 2023-11-07 - 18 days
Short mv avg 12 mos Sell 2023-11-28 - 4 days
Long mv avg 12 mos Buy 2023-08-23 - 71 days
Short/Long mv avg 12 mos Buy 2023-08-31 - 65 days
Pivot Short Sell 2023-10-24 - 28 days
Bollinger Buy 2023-11-15 - 12 days
MACD Buy No Dates Stored For This Signal

Signals Effectiveness

Backtesting is not only a way to check stock signal accuracy, but also a tool to continually improvement. Data can be used for self adjustment as each stock has an individual behavior.

Accuracy and return is not the same. A stock signal may provide low statistical accuracy, but the signals may prove high return in average.

Sharp market dips or fundamental changes (earning reports, news updates etc), may force a short term reaction and disturb the signals (Signals may jump quickly from buy to sell, just to return to buy).

Stock Score

Buy Signals
Sell Signals

Bollinger Bands

Buy Signals
Sell Signals

MACD

Buy Signals
Sell Signals

Moving Average (7d)

Buy Signals
Sell Signals
Click to get the best stock tips daily for free!

About Seattle Genetics

Seattle Genetics Seagen Inc., a biotechnology company, develops and commercializes therapies for the treatment of cancer in the United States and internationally. The company offers ADCETRIS, an antibody-drug conjugate (ADC) for the treatment of patients with Hodgkin lymphoma or CD30-positive T-cell lymphomas; PADCEV, an ADC targeting Nectin-4 for the treatment of advanced or metastatic urothelial cancer; and TUKYSA, an oral small molecule tyrosine kinase inhibit... SGEN Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT